[Treatment of scalp psoriasis. A new dexamethasone preparation in a double-blind trial with hydrocortisone-17-butyrate].
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012536:Scalp Dermatoses / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; C007975:hydrocortisone-17-butyrate; D003907:Dexamethasone; D006854:Hydrocortisone
Behandlung der Kopfhautpsoriasis. Ein neues Dexamethason-Präparat im Doppelblindversuch mit Hydrocortison-17-butyrat.